Georgina Bough1, Nicholas J Lambert2,3, Florin Djendov1, Claire Jackson4. 1. Department of Paediatric Surgery, Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ, UK. 2. Department of Physics, University of Otago, Dunedin, New Zealand. 3. The Dodd-Walls Centre for Photonic and Quantum Technologies, University of Otago, Dunedin, New Zealand. 4. Department of Paediatric Surgery, Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ, UK. claire.jackson@addenbrookes.nhs.uk.
Abstract
PURPOSE: To explore the factors involved in the demise of tunnelled central vascular access devices (CVADs) in children and describe patterns of failure. METHODS: A retrospective study including children under 16 years of age undergoing CVAD insertion in a tertiary centre between October 2014 and December 2019. The Kaplan-Meier estimator was used to study CVAD survival and piecewise exponential curves to approximate hazard rates. Related factors were analysed using multivariable regression. RESULTS: Totally, 684 CVADs were inserted in 499 children. Devices were in situ for 213,821 days (median 244.5). Of those, 261 CVADs (38.2%) failed prematurely; 176 (67%) required replacement. Tunnelled external lines (TELs) failed more frequently than totally implantable devices (p < 0.005).TEL displacement occurred in two high-risk phases, falling to baseline after 90 days. Low age at device insertion and open placement were strongly associated with an increased failure rate. Previous CVAD failure did not increase subsequent failure rate. Premature failure increased procedural cost by £153,949 per year. CONCLUSIONS: TIDs should be placed in preference to TELs where appropriate. TELs are at highest risk of displacement for 90 days and must be well secured for this duration. Meticulous line care offers significant potential cost savings by reducing line replacements. LEVEL OF EVIDENCE: Level III.
PURPOSE: To explore the factors involved in the demise of tunnelled central vascular access devices (CVADs) in children and describe patterns of failure. METHODS: A retrospective study including children under 16 years of age undergoing CVAD insertion in a tertiary centre between October 2014 and December 2019. The Kaplan-Meier estimator was used to study CVAD survival and piecewise exponential curves to approximate hazard rates. Related factors were analysed using multivariable regression. RESULTS: Totally, 684 CVADs were inserted in 499 children. Devices were in situ for 213,821 days (median 244.5). Of those, 261 CVADs (38.2%) failed prematurely; 176 (67%) required replacement. Tunnelled external lines (TELs) failed more frequently than totally implantable devices (p < 0.005).TEL displacement occurred in two high-risk phases, falling to baseline after 90 days. Low age at device insertion and open placement were strongly associated with an increased failure rate. Previous CVAD failure did not increase subsequent failure rate. Premature failure increased procedural cost by £153,949 per year. CONCLUSIONS: TIDs should be placed in preference to TELs where appropriate. TELs are at highest risk of displacement for 90 days and must be well secured for this duration. Meticulous line care offers significant potential cost savings by reducing line replacements. LEVEL OF EVIDENCE: Level III.
Entities:
Keywords:
Central line infection; Central vascular access; Cost; Failure; Hickman; Paediatric; Portacath
Authors: S S Kaufman; J B Atkinson; A Bianchi; O J Goulet; D Grant; A N Langnas; S V McDiarmid; N Mittal; J Reyes; A G Tzakis Journal: Pediatr Transplant Date: 2001-04
Authors: Aurelia B Fu; Erica I Hodgman; Lorraine S Burkhalter; Rachel Renkes; Tamra Slone; Adam C Alder Journal: J Surg Res Date: 2016-06-24 Impact factor: 2.192
Authors: Ceder H van den Bosch; J Tjomme van der Bruggen; Florine N J Frakking; Cecilia E J Terwisscha van Scheltinga; Cornelis P van de Ven; Martine van Grotel; Lianne M Wellens; Yvette G T Loeffen; Marta Fiocco; Marc H W A Wijnen Journal: J Pediatr Surg Date: 2018-10-30 Impact factor: 2.545
Authors: Joanna C Thorn; Emma L Turner; Luke Hounsome; Eleanor Walsh; Liz Down; Julia Verne; Jenny L Donovan; David E Neal; Freddie C Hamdy; Richard M Martin; Sian M Noble Journal: BMJ Open Date: 2016-04-29 Impact factor: 2.692